155 related articles for article (PubMed ID: 6975197)
1. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man.
Muirhead N; Catto GR; Gvozdanovic S; Gvozdanovic D; Edward N
Clin Sci (Lond); 1981 Dec; 61(6):723-7. PubMed ID: 6975197
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
3. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
Colodro IH; Brickman AS; Coburn JW; Osborn TW; Norman AW
Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients.
Llach F; Brickman AS; Coburn JW
Contrib Nephrol; 1980; 18():212-7. PubMed ID: 7353377
[TBL] [Abstract][Full Text] [Related]
6. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
Vattimo A
Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1 alpha-hydroxylated metabolites of cholecalciferol on intestinal radiocalcium absorption in goats.
Hove K
Br J Nutr; 1984 Jan; 51(1):157-64. PubMed ID: 6546296
[TBL] [Abstract][Full Text] [Related]
8. Early and direct effect of 1,25-dihydroxycholecalciferol on calcium uptake by duodena of rachitic chicks.
Fullmer CS; Brindak ME; Edelstein S; Wasserman RH
Proc Soc Exp Biol Med; 1984 Dec; 177(3):455-8. PubMed ID: 6334856
[TBL] [Abstract][Full Text] [Related]
9. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
Gennari C; Agnusdei D; Nardi P; Civitelli R
J Clin Endocrinol Metab; 1990 Nov; 71(5):1288-93. PubMed ID: 2229286
[TBL] [Abstract][Full Text] [Related]
10. Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease.
Rutherford WE; Blondin J; Hruska K; Kopelman R; Klahr S; Slatopolsky E
Kidney Int; 1975 Nov; 8(5):320-4. PubMed ID: 1195563
[TBL] [Abstract][Full Text] [Related]
11. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
Binswanger U; Schiffl H; Huggler M; Becker C
Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S
Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529
[TBL] [Abstract][Full Text] [Related]
13. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
[No Abstract] [Full Text] [Related]
14. The effect of the dihydroxylated metabolites of vitamin D and dietary phosphate restriction on bone disease in uraemic rats.
Main J; Velasco N; Heyes SD; Whiting P; Fraser RA; Catto GR
Clin Sci (Lond); 1986 Nov; 71(5):539-43. PubMed ID: 3490349
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1alpha-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 3 deoxy-1alpha-hydroxycholecalciferol, 24R, 25-dihydroxycholecalciferol and successful renal transplantation on calcium absorption in haemodialysis patients.
Pierides AM; Aljama P; Kerr DN; Scott M; Norman AW
Nephron; 1978; 20(4):203-11. PubMed ID: 345140
[TBL] [Abstract][Full Text] [Related]
17. [Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?].
Sebert JL; Fournier A; Lambrey G; Morinière P; Decourcelle PH; Makdassi R; De Frémont JF
Nephrologie; 1982; 3(3):133-41. PubMed ID: 6292757
[TBL] [Abstract][Full Text] [Related]
18. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
Caniggia A; Vattimo A
Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
[TBL] [Abstract][Full Text] [Related]
19. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
Massry SG; Tuma S; Dua S; Goldstein DA
J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
[TBL] [Abstract][Full Text] [Related]
20. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
Christiansen C; Rødbro P; Naestoft J; Christensen MS
Clin Endocrinol (Oxf); 1981 Sep; 15(3):237-42. PubMed ID: 6273028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
